Neurocrine Biosciences, Inc. will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18, 2025. Chief Executive Officer Kyle Gano and Chief Medical Officer ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...

In a report released today, Suthan Sukumar from Stifel Nicolaus maintained a Buy rating on Sylogist (SYZ – Research Report), with a price ...

A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly misleading ...

SAN DIEGO, March 11, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual ... on the website approximately one hour after the conclusion ...

The largest arbitration award granted to retail clients is the third ruling against Stifel involving advisor Chuck Roberts. More cases are in the pipeline.

Stifel Financial Corporation (Symbol: SF) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

The weather is warming up, but there’s still an icy chill in St. Louis as a monthlong stretch of major hockey events begins ...

Operator Greetings, and welcome to the Xponential Fitness, Inc. fourth quarter and full year 2024 earnings call. At this time ...

Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Discover why Everus Construction Group, Inc.'s stock is declining despite strong demand and solid cash flow. Read more on ECG ...